PUBLISHER: Grand View Research | PRODUCT CODE: 1772262
PUBLISHER: Grand View Research | PRODUCT CODE: 1772262
The U.S. ligation devices market size was estimated at USD 619.9 million in 2024 and is expected to grow at a CAGR of 6.7% from 2025 to 2033 to reach a value of USD 1,108.6 million in 2033. The market growth is driven by several factors, including the increasing volume of surgical procedures, fueled by an aging population and the rising prevalence of chronic diseases such as cardiovascular conditions and cancer. Technological advancements, such as robotic-assisted ligation systems and the development of innovative materials, enhance surgical precision and patient outcomes, further fueling market expansion.
The growing preference for minimally invasive surgical techniques also contributes to market growth, as ligation devices are essential. The U.S. is witnessing a significant rise in overall surgical interventions owing to the aging population and the rising prevalence of chronic and degenerative diseases. As the proportion of Americans aged 65 and older continues to increase, there is a corresponding rise in age-related conditions such as cardiovascular disease, colorectal cancer, and urologic disorders, which significantly increases demand for surgical treatment involving ligation. According to the Population Reference Bureau (PRB), the elderly population in the U.S. aged 65 years is expected to increase from around 58 million in 2022 to approximately 82 million by 2050. Geriatric patients undergoing procedures such as bowel resections, hernia repairs, and prostatectomies benefit from the reduced operative time and lower risk of complications offered by advanced ligation systems.
Moreover, procedures in gastrointestinal, gynecological, cardiovascular, and urological specialties are witnessing a surge due to the growing burden of conditions such as cancer, diabetes, and heart disease. According to the American Heart Association (AHA), in January 2024, someone dies of a stroke every 3 minutes and 14 seconds, highlighting the urgent need for timely surgical management. This expanding surgical demand is prompting medical device companies to invest in advanced ligation technologies that support efficiency and patient safety in high-volume surgical environments. For instance, in February 2024, Ethicon (a Johnson & Johnson MedTech company) announced enhancements to its surgical stapling and ligation devices, optimized for precision and tissue management during minimally invasive surgeries. Similarly, Medtronic is expanding its vessel sealing product line to support broader applications in laparoscopic and open surgeries, addressing the needs of growing procedure volumes.
U.S. Ligation Devices Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. ligation devices market report based on product, application, procedure, and end use: